Emilie Lalonde
Emilie Lalonde
ABMGG Laboratory Fellow, Children's Hospital of Philadelphia and University of Pennsylvania
Verified email at email.chop.edu
Title
Cited by
Cited by
Year
What can exome sequencing do for you?
J Majewski, J Schwartzentruber, E Lalonde, A Montpetit, N Jabado
Journal of medical genetics 48 (9), 580-589, 2011
3962011
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736-745, 2015
3232015
Genomic hallmarks of localized, non-indolent prostate cancer
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359-364, 2017
2942017
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
2352014
Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next‐generation exome sequencing
E Lalonde, S Albrecht, KCH Ha, K Jacob, N Bolduc, C Polychronakos, ...
Human mutation 31 (8), 918-923, 2010
1382010
RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression
E Lalonde, KCH Ha, Z Wang, A Bemmo, CL Kleinman, T Kwan, ...
Genome research 21 (4), 545-554, 2011
1252011
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies
MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ...
European urology 72 (5), 665-674, 2017
902017
Familial rhabdoid tumour 'avant la lettre'—from pathology review to exome sequencing and back again
L Witkowski, E Lalonde, J Zhang, S Albrecht, N Hamel, L Cavallone, ...
The Journal of pathology 231 (1), 35-43, 2013
632013
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
GI Allen, N Amoroso, C Anghel, V Balagurusamy, CJ Bare, D Beaton, ...
Alzheimer's & Dementia 12 (6), 645-653, 2016
622016
An RMND1 Mutation Causes Encephalopathy Associated with Multiple Oxidative Phosphorylation Complex Deficiencies and a Mitochondrial Translation Defect
A Janer, H Antonicka, E Lalonde, T Nishimura, F Sasarman, GK Brown, ...
The American Journal of Human Genetics 91 (4), 737-743, 2012
592012
Mutations in SCARF2 are responsible for Van Den Ende-Gupta syndrome
N Anastasio, T Ben-Omran, A Teebi, KCH Ha, E Lalonde, R Ali, ...
The American Journal of Human Genetics 87 (4), 553-559, 2010
512010
Epigenetic markers of prostate cancer in plasma circulating DNA
R Cortese, A Kwan, E Lalonde, O Bryzgunova, A Bondar, Y Wu, ...
Human molecular genetics 21 (16), 3619-3631, 2012
472012
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair
A Dal Pra, E Lalonde, J Sykes, F Warde, A Ishkanian, A Meng, C Maloff, ...
Clinical Cancer Research 19 (18), 5202-5209, 2013
422013
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
KCH Ha, E Lalonde, L Li, L Cavallone, R Natrajan, MB Lambros, ...
BMC medical genomics 4 (1), 75, 2011
392011
Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors
E Lalonde, R Alkallas, MLK Chua, M Fraser, S Haider, A Meng, J Zheng, ...
European urology 72 (1), 22-31, 2017
362017
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
A Berlin, E Lalonde, J Sykes, G Zafarana, KC Chu, VR Ramnarine, ...
Oncotarget 5 (22), 11081, 2014
302014
PRiMeUM: a model for predicting risk of metastasis in uveal melanoma
J Vaquero-Garcia, E Lalonde, KG Ewens, J Ebrahimzadeh, ...
Investigative ophthalmology & visual science 58 (10), 4096-4105, 2017
282017
Mining human prostate cancer datasets: The “camcAPP” Shiny App
MJ Dunning, SL Vowler, E Lalonde, H Ross-Adams, P Boutros, IG Mills, ...
EBioMedicine 17, 5-6, 2017
222017
Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient
J Zhang, Y Shi, E Lalonde, L Li, L Cavallone, A Ferenczy, WH Gotlieb, ...
BMC cancer 13 (1), 146, 2013
202013
Germline mutations in the kallikrein 6 region and predisposition for aggressive prostate cancer
L Briollais, H Ozcelik, J Xu, M Kwiatkowski, E Lalonde, DH Sendorek, ...
JNCI: Journal of the National Cancer Institute 109 (4), 2017
122017
The system can't perform the operation now. Try again later.
Articles 1–20